tiprankstipranks
Trending News
More News >
Austar Lifesciences Ltd. (HK:6118)
:6118
Hong Kong Market

Austar Lifesciences Ltd. (6118) Financial Statements

Compare
0 Followers

Austar Lifesciences Ltd. Financial Overview

Austar Lifesciences Ltd.'s market cap is currently HK$451.07M. The company's EPS TTM is HK$0.052; its P/E ratio is 11.62; Austar Lifesciences Ltd. is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.50B¥ 1.76B¥ 2.16B¥ 2.02B¥ 1.30B
Gross Profit¥ 301.22M¥ 336.05M¥ 488.80M¥ 479.01M¥ 323.53M
Operating Income¥ 35.18M¥ -29.99M¥ 116.37M¥ 311.92M¥ 30.73M
EBITDA¥ 70.71M¥ 25.15M¥ 159.79M¥ 130.62M¥ 39.83M
Net Income¥ 16.08M¥ -113.47M¥ 87.46M¥ 277.30M¥ 33.10M
Balance Sheet
Cash & Short-Term Investments¥ 167.81M¥ 173.76M¥ 148.13M¥ 219.74M¥ 178.11M
Total Assets¥ 2.08B¥ 2.16B¥ 2.39B¥ 2.04B¥ 1.38B
Total Debt¥ 401.95M¥ 496.20M¥ 336.55M¥ 155.22M¥ 76.47M
Net Debt¥ 235.15M¥ 332.43M¥ 202.92M¥ -43.22M¥ -101.48M
Total Liabilities¥ 1.29B¥ 1.38B¥ 1.51B¥ 1.26B¥ 854.27M
Stockholders' Equity¥ 791.41M¥ 773.01M¥ 896.94M¥ 786.58M¥ 517.90M
Cash Flow
Free Cash Flow¥ 78.31M¥ -133.59M¥ -155.25M¥ -204.02M¥ 25.68M
Operating Cash Flow¥ 98.81M¥ -62.65M¥ -37.93M¥ -103.45M¥ 52.22M
Investing Cash Flow¥ 4.43M¥ -54.47M¥ -153.14M¥ 65.02M¥ -59.81M
Financing Cash Flow¥ -101.32M¥ 147.12M¥ 125.30M¥ 59.35M¥ -5.51M
Currency in CNY

Austar Lifesciences Ltd. Earnings and Revenue History

Austar Lifesciences Ltd. Debt to Assets

Austar Lifesciences Ltd. Cash Flow

Austar Lifesciences Ltd. Forecast EPS vs Actual EPS